Literature DB >> 11229834

Infectious diseases: considerations for the 21st century.

A S Fauci1.   

Abstract

The discipline of infectious diseases will assume added prominence in the 21st century in both developed and developing nations. To an unprecedented extent, issues related to infectious diseases in the context of global health are on the agendas of world leaders, health policymakers, and philanthropies. This attention has focused both on scientific challenges such as vaccine development and on the deleterious effects of infectious diseases on economic development and political stability. Interest in global health has led to increasing levels of financial support, which, combined with recent technological advances, provide extraordinary opportunities for infectious disease research in the 21st century. The sequencing of human and microbial genomes and advances in functional genomics will underpin significant progress in many areas, including understanding human predisposition and susceptibility to disease, microbial pathogenesis, and the development new diagnostics, vaccines, and therapies. Increasingly, infectious disease research will be linked to the development of the medical infrastructure and training needed in developing countries to translate scientific advances into operational reality.

Entities:  

Mesh:

Year:  2001        PMID: 11229834     DOI: 10.1086/319235

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  85 in total

1.  Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals.

Authors:  Juri Katchanov; Kai Wöstmann; Daniela Tominski; Laura Jefferys; Anna Liedtke; Arnim Schneider; Hortense Slevogt; Keikawus Arastéh; Hartmut Stocker
Journal:  Infection       Date:  2015-08-27       Impact factor: 3.553

Review 2.  Expression library immunization: a road map for discovery of vaccines against infectious diseases.

Authors:  Adel M Talaat; Katherine Stemke-Hale
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

3.  Combating emerging infectious diseases in India: orchestrating a symphony.

Authors:  Lalit Kant
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

4.  A microfluidic platform for real-time and in situ monitoring of virus infection process.

Authors:  Na Xu; Zhen-Feng Zhang; Li Wang; Bo Gao; Dai-Wen Pang; Han-Zhong Wang; Zhi-Ling Zhang
Journal:  Biomicrofluidics       Date:  2012-09-27       Impact factor: 2.800

5.  Emerging and re-emerging viruses in the era of globalisation.

Authors:  Alessandra Zappa; Antonella Amendola; Luisa Romanò; Alessandro Zanetti
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

6.  Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence.

Authors:  Naomi L Forrester; Joan L Kenney; Eleanor Deardorff; Eryu Wang; Scott C Weaver
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

7.  [Severe Acute Respiratory Syndrome. A new emergent infectious disease].

Authors:  Lluís Salleras
Journal:  Med Clin (Barc)       Date:  2003-05-03       Impact factor: 1.725

8.  Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics.

Authors:  Michael J Pucci; Joanne J Bronson; John F Barrett; Kenneth L DenBleyker; Linda F Discotto; Joan C Fung-Tomc; Yasutsugu Ueda
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Intracellular expression of Peptide fusions for demonstration of protein essentiality in bacteria.

Authors:  R Edward Benson; Elizabeth B Gottlin; Dale J Christensen; Paul T Hamilton
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Advocacy, promotion and e-learning: Supercourse for zoonosis.

Authors:  Gino C Matibag; Manabu Igarashi; Ron E La Porte; Hiko Tamashiro
Journal:  Environ Health Prev Med       Date:  2005-09       Impact factor: 3.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.